Dishman Carbogen Amcis Current Share Price | Dishman Carbogen Amcis Stock Screener
DCAL
Pharmaceuticals
Dishman Carbogen Amcis Current Stock Price Today
Live Share Price NSE
₹170.52
▲
8.41 (5.19%)
Live Share Price BSE
₹170.45
▲
8.40 (5.18%)
As of September 18, 2026, the live Dishman Carbogen Amcis share price (NSE: DCAL) is ₹170.52 on NSE and ₹170.45 on BSE, up 5.19% from the previous close, with shares trading between ₹157.60 and ₹171.69 in today's trading session, and a 52-week range of ₹129.97–₹314.00.
Browse DCAL balance sheet details to support your investment research.
Use the Dishman Carbogen Amcis stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Dishman Carbogen Amcis Market Cap
₹2,558.07 Cr.
DCAL P/E Ratio (TTM)
162.43
Dishman Carbogen Amcis P/B Ratio
0.39
EPS (TTM)
₹6.22
Dividend Yield
-
Debt to Equity
0.44
DCAL 52 Week High
₹314.00
Dishman Carbogen Amcis 52 Week Low
₹129.97
Operating Margin
9.00%
Profit Margin
-8.33%
DCAL Revenue (TTM)
₹696.00
EBITDA
₹77.00
Net Income
₹-58.00
Total Assets
₹11,923.00
Total Equity
₹6,677.00
Dishman Carbogen Amcis Current Share Price Chart
Track the current Dishman Carbogen Amcis share price and stock price with an interactive chart. Analyse DCAL price trends, trading volume, historical performance, and volatility across different timeframes — the complete Dishman Carbogen Amcis stock quote in one place.
Dishman Carbogen Amcis Company Profile - Fundamental Screener
Screen Dishman Carbogen Amcis company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for DCAL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE385W01011
Dishman Carbogen Amcis Balance Sheet Screener
Screen DCAL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 11,923 | 9,999 | 9,581 | 9,454 | 8,638 | 8,366 | 8,200 | 7,329 | 7,177 | 6,593 |
| Current Assets | 2,842 | 2,200 | 1,928 | 1,918 | 1,839 | 1,704 | 1,779 | 1,554 | 1,546 | 1,245 |
| Fixed Assets | 8,076 | 7,055 | 6,724 | 6,188 | 5,773 | 5,698 | 5,678 | 5,098 | 5,066 | 4,852 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 2,929 | 2,243 | 1,399 | 1,845 | 1,669 | 1,377 | 916 | 751 | 891 | 786 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 6,677 | 5,832 | 5,628 | 5,810 | 5,549 | 5,699 | 5,715 | 5,379 | 5,107 | 4,814 |
| Share Capital | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 32 | 32 | 0 |
| Reserves & Surplus | 6,646 | 5,800 | 5,596 | 5,778 | 5,518 | 5,668 | 5,684 | 5,347 | 5,075 | 4,814 |
Dishman Carbogen Amcis Income Statement Screener - Profit & Revenue Analysis
Screen Dishman Carbogen Amcis income statement and profit fundamentals.
Analyze DCAL quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Dishman Carbogen Amcis share price evaluation.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 696 | 868 | 727 | 661 | 733 | 724 | 690 | 796 | 525 | 662 | 657 | 595 | 730 | 625 | 646 |
| Expenses | 619 | 690 | 607 | 504 | 570 | 575 | 542 | 645 | 500 | 595 | 610 | 529 | 602 | 613 | 529 |
| EBITDA | 77 | 178 | 120 | 157 | 163 | 149 | 148 | 151 | 25 | 67 | 47 | 66 | 128 | 13 | 118 |
| Operating Profit % | 9.00% | 19.00% | 16.00% | 23.00% | 19.00% | 20.00% | 21.00% | 18.00% | 4.00% | 9.00% | 6.00% | 10.00% | 17.00% | 1.00% | 17.00% |
| Depreciation | 91 | 89 | 84 | 84 | 81 | 79 | 72 | 72 | 71 | 85 | 80 | 75 | 70 | 76 | 50 |
| Interest | 37 | 43 | 46 | 42 | 43 | 42 | 49 | 37 | 32 | 31 | 33 | 28 | 29 | 24 | 22 |
| Profit Before Tax | -51 | 46 | -10 | 31 | 39 | 28 | 27 | 42 | -78 | -49 | -66 | -36 | 30 | -88 | 46 |
| Tax | 7 | 24 | 3 | -35 | 15 | -15 | 22 | 9 | 0 | 21 | -7 | 5 | 13 | -17 | -1 |
| Net Profit | -58 | 22 | -13 | 65 | 23 | 43 | 5 | 33 | -78 | -70 | -60 | -41 | 17 | -71 | 47 |
| EPS | -3.69 | 1.39 | -0.83 | 4.16 | 1.49 | 2.75 | 0.30 | 2.11 | -4.95 | -4.46 | -3.80 | -2.61 | 1.08 | -4.51 | 3.00 |
Dishman Carbogen Amcis Cash Flow Screener - Liquidity Fundamentals
Screen DCAL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 492 | 371 | 379 | 266 | 355 | 513 | 585 | 282 | 226 | 303 |
| Investing Activities | -245 | -192 | -225 | -494 | -619 | -380 | -442 | -169 | -297 | -107 |
| Financing Activities | 201 | -102 | -22 | 250 | 130 | -11 | -98 | -102 | 78 | -137 |
| Net Cash Flow | 447 | 77 | 132 | 22 | -133 | 122 | 46 | 11 | 7 | 59 |
Dishman Carbogen Amcis Shareholding Pattern Screener
See Dishman Carbogen Amcis shareholding pattern with promoter, FII, and DII holdings.
Check Dishman Carbogen Amcis promoter holding and ownership changes for DCAL on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 59.32% | 59.32% | 59.32% | 59.32% | 59.32% | 59.32% | 59.32% | 59.32% |
| FII Holding | 7.45% | 6.86% | 9.49% | 9.93% | 8.07% | 7.66% | 8.70% | 8.04% |
| DII Holding | 1.63% | 2.07% | 1.26% | 1.27% | 1.37% | 1.27% | 2.37% | 1.48% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 27.20% | 27.32% | 25.31% | 25.36% | 26.84% | 27.31% | 25.17% | 27.10% |
| Other Holding | 4.40% | 4.43% | 4.62% | 4.11% | 4.39% | 4.44% | 4.45% | 4.06% |
| Shareholder Count | 49,009 | 49,430 | 50,757 | 49,744 | 49,455 | 48,481 | 50,656 | 53,683 |
Dishman Carbogen Amcis Share Dividend Screener - Share Yield Analysis
Check Dishman Carbogen Amcis dividend history with payout and yield data.
View Dishman Carbogen Amcis dividend details including ex-dates and amounts for DCAL stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.20 | 0.37% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹1.20 | 0.37% |
Dishman Carbogen Amcis Stock Index Membership
See which indices include Dishman Carbogen Amcis stock.
Check DCAL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT
Dishman Carbogen Amcis Market Events Screener - Corporate Actions
Get Dishman Carbogen Amcis corporate actions including splits, bonuses, and buybacks.
Check Dishman Carbogen Amcis stock events that may affect DCAL share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-30 | 2026-09-30 | Annual General Meeting | NA | -4.48% |
| 2026-08-14 | 2026-08-14 | Quarterly Result Announcement | NA | 2.61% |
| 2026-06-19 | 2026-06-19 | Extraordinary General Meeting | NA | -14.62% |
| 2026-05-19 | 2026-05-19 | Quarterly Result Announcement | NA | 6.64% |
| 2026-02-03 | 2026-02-03 | Quarterly Result Announcement | NA | 4.54% |
| 2025-11-04 | 2025-11-04 | Quarterly Result Announcement | NA | -0.44% |
| 2025-09-29 | 2025-09-29 | Annual General Meeting | NA | 3.83% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -0.81% |
| 2025-05-21 | 2025-05-21 | Quarterly Result Announcement | NA | 1.32% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -5.97% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -2.31% |
| 2024-09-27 | 2024-09-27 | Annual General Meeting | NA | -4.79% |
| 2017-03-27 | 2017-03-27 | Change Of Name | NA | - |
Dishman Carbogen Amcis Competitors Screener - Peer Comparison
Screen DCAL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 440,278 | 36.48 | 61,674 | 12.69% | 11,565 | 33.19 |
| Divis Laboratories | 244,178 | 84.64 | 11,067 | 13.95% | 2,568 | 59.21 |
| Torrent Pharmaceuticals | 184,478 | 87.77 | 13,886 | 20.34% | 2,138 | 44.26 |
| Zydus Life Science | 110,585 | 24.32 | 27,658 | 17.64% | 5,026 | 41.59 |
| Cipla | 109,140 | 32.86 | 29,045 | 2.24% | 3,870 | 32.08 |
| Laurus Labs | 104,025 | 97.64 | 6,868 | 22.01% | 890 | 60.27 |
| Dr Reddys Laboratories | 95,570 | 30.44 | 35,059 | 3.90% | 4,158 | 41.23 |
| Aurobindo Pharma | 95,513 | 25.98 | 34,145 | 5.56% | 3,503 | 53.00 |
| Lupin | 94,336 | 17.27 | 29,039 | 26.75% | 5,356 | 24.64 |
| Mankind Pharma | 94,184 | 45.49 | 14,636 | 14.85% | 1,938 | 37.66 |
Dishman Carbogen Amcis Company Announcements - News Screener
Screen DCAL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-15 | Disclosure Pursuant To Regulations 30 And 51 Of SEBI (LODR) Regulations 2015: The CompanyS Wholly Owned Subsidiary CARBOGEN AMCIS AG Successfully Completed US FDA Inspection At Its Manufacturing Site Located At Vionnaz Switzerland Without Any Observations | - |
| 2026-09-11 | ANNUAL GENERAL MEETING AND E-VOTING NOTICE - NEWS PAPER ADVERTISEMENT | - |
| 2026-09-08 | SUBMISSION OF NOTICE OF 19TH ANNUAL GENERAL MEETING ALONGWITH ANNUAL REPORT FOR THE FINANCIAL YEAR 2025-26 AS PER REGULATIONS 34 AND 53 OF SEBI (LODR) REGULATIONS 2015 | - |
| 2026-09-08 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-09-08 | Reg. 34 (1) Annual Report. | - |
| 2026-09-02 | NEWSPAPER ADVERTISEMENT FOR INFORMATION REGARDING THE 19TH ANNUAL GENERAL MEETING TO BE HELD THROUGH VIDEO CONFERENCING OR OTHER AUDIO VISUAL MEANS | - |
| 2026-08-31 | INTIMATION REGARDING DATE OF 19TH ANNUAL GENERAL MEETING | - |
| 2026-08-29 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-21 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-17 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-17 | Announcement under Regulation 30 (LODR)-Allotment | - |
| 2026-08-17 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-14 | Board Meeting Outcome for UN-AUDITED FINANCIAL RESULTS AND STATUTORY AUDITORS LIMITED REVIEW REPORT FOR THE FIRST QUARTER ENDED 30/06/2026 | - |
| 2026-08-14 | UN-AUDITED FINANCIAL RESULTS AND STATUTORY AUDITORS LIMITED REVIEW REPORT FOR THE FIRST QUARTER ENDED 30/06/2026 | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-12 | Board Meeting Outcome for Board Meeting Outcome For BOARD APPROVES ISSUE OF SENIOR SECURED RATED LISTED TRANSFERABLE REDEEMABLE TAXABLE NON-CONVERTIBLE DEBENTURES AGGREGATING UP TO RS. 75 CRORES | - |
| 2026-08-10 | Board Meeting Intimation for Considering Taking On Record And Approving The Un-Audited Financial Results Of The Company For The First Quarter Ended On 30Th June 2026. | - |
| 2026-08-07 | Board Meeting Intimation for Considering And Approving The Proposal Of Fund Raising By Way Of Issuance Of Non-Convertible Debentures By Way Of Private Placement Subject To Such Regulatory Or Statutory Approvals As May Be Required | - |
| 2026-07-17 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |